Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Rosuvastatin Treatment for Intracranial Arterial Stenosis Based on Magnetic Resonance Angiography
NCT02341794Unknown
- Sponsor
- Tokyo Medical University
- Start
- Jan 2015
- Primary completion
- Dec 2017
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Open-label, single-arm trial of rosuvastatin in Intracranial arterial stenosis (ICAS), sponsored by Tokyo Medical University. Primary endpoint: Progression of intracranial arterial stenosis at 2 years. Status: unknown.
02
Drugs
rosuvastatin
03
Conditions
Intracranial arterial stenosis (ICAS)
Beyond the preview
Go deeper on NCT02341794.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02341794.